Clinical trial to test potential for blood-based biopsies to identify cancer patients more likely to response to treatment with immunotherapy
An FAU professor and a high school senior from MSD have published a study on homicide rates in Baltimore and New York City. They note marked differences between these “peer” cities according to 19 population-based characteristics from the U.S. Centers for Disease Control and Prevention. The root causes for these differences are complex and multifactorial, and raise several major clinical and contemporary medical policy issues. The vast majority of these U.S. homicides are attributable to firearms.
Penn Medicine's new Molecular Integration in Neurological Diagnosis Initiative brings the power of precision medicine to Parkinson’s disease research.
Foundation Awards Presented for Ethics and Creativity in Medical Research, and Societal Impact in Business & Biotechnology
Runny noses are annoying and easy to dismiss. And that’s exactly why one doctor waited so long to seek medical attention. Now, he realizes that mistake could have cost him his eyesight, or even his life.
Dr. Stuart Chalk, a University of North Florida chemistry professor, has been awarded a grant from the National Science Foundation to test and improve upon his data science framework, SciData, which will help make the integration of scientific data more efficient for researchers.
A special November issue of Health Physics journal presents 13 original research papers, reviews, and commentaries related to women’s contributions to and experiences in radiation protection and safety. Health Physics, the official journal of the Health Physics Society (HPS) is published in the Lippincott portfolio by Wolters Kluwer.
A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology. The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory and Critical Care Medicine.
Study serves as a warning about excessive use or over-dosage
ISPOR, the professional society for health economics and outcomes research (HEOR), announced that it has published a new Global Healthcare Systems Road Map—Egypt Pharmaceuticals.
The Braverman Distinguished Award is presented annually to an individual who: demonstrates excellence and passion for mentoring fellows, students, and junior faculty; has a long history of productive thyroid research; and is devoted to the ATA. The American Thyroid Association (ATA) announces with pleasure that the 2018 Lewis E. Braverman Distinguished Award recipient will be Dr. R. Michael Tuttle, currently Clinical Director of the Endocrinology Service and Attending Physician at Memorial Hospital for Cancer and Allied Diseases in New York City.
The American Thyroid Association (ATA) is pleased to announce that the 2018 Paul Starr Award recipient and lecturer will be Dr. Scott A. Rivkees, Professor and Chair, as well as Nemours Eminent Scholar, at the University of Florida Department of Pediatrics. Dr. Rivkees is also Physician-in-Chief at Shands Children’s Hospital in Gainesville, Academic Chair of Pediatrics at Arnold Palmer Hospital in Orlando, and University of Florida Chair of Pediatrics at Studer Family Children’s Hospital at Sacred Heart in Pensacola. The Starr Award is presented to an outstanding contributor to clinical thyroidology. At the ATA Annual Meeting in Washington, DC, Dr. Rivkees will deliver the Paul Starr Award Lecture at 1:00 pm on October 4, 2018, on “Unmasking the Problems With Antithyroid Medication Safety.”
.The 88th Annual Meeting of the American Thyroid Association (ATA) is to be held October 3-7, 2018 at the Marriott Marquis Washington DC. This year the program committee, comprised of experts of all thyroid disciplines, has developed a program featuring the latest advances in basic/ translational and clinical thyroidology (www.thyroid.org). Meeting registration is on track to generate the highest attendance we have ever had for an ATA meeting. Washington, DC is a world-class destination with many stellar cultural, musical and museum attractions (within walking distance of the headquarters’ hotel) available to attendees and their families.
The American Thyroid Association (ATA) is pleased to announce that the 2018 Sidney H. Ingbar Distinguished Lectureship Award recipient will be Dr. Anthony N. Hollenberg, currently the Sanford I. Weill Chair, Weill Department of Medicine, Weill Cornell Medicine and Physician-in Chief, NewYork-Presbyterian - Weill Cornell Medical Center. Dr. Hollenberg is former Chief of Endocrinology, Diabetes and Metabolism Beth Israel Deaconess Medical Center and Professor of Medicine, Harvard Medical School. The Ingbar Award recognizes an established investigator who has made outstanding contributions to thyroid-related research over many years. The award honors the memory of Dr. Sidney H. Ingbar, a brilliant innovator who was once Chief of the Beth Israel Thyroid Unit, a position Dr. Hollenberg recently held. The award is conferred at the ATA Annual Meeting, held this year from October 3 to 7 in Washington, DC. On Friday, October 5, at 1 pm, Dr. Hollenberg will deliver the Sidney H. Ingbar Disti
The American Thyroid Association (ATA) is pleased to announce that the 2018 Distinguished Service Award recipient will be Dr. David H. Sarne, currently Clinical Associate in the Department of Medicine at the University of Chicago.
Today, the U.S. House of Representatives passed H.R. 6, the SUPPORT for Patients and Communities Act, legislation to address the opioid crisis, which includes provisions supported by the American Society of Anesthesiologists (ASA) to advance opioid reducing initiatives in the surgical setting.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective. But for the majority of non-small cell lung cancer patients, targeted therapies are limited and many patients develop resistance to treatment, highlighting the need for other options.
In a study examining the potential impact of 2001-02 Medicaid expansions by Arizona, Maine and New York – expansions that occurred just prior to the rise in overdose mortality nationwide – researchers from the Perelman School of Medicine at the University of Pennsylvania found that from the time of these expansions through 2008, overdose mortality rates (mostly driven by fatal overdoses of opioids) rose significantly less in the expansion states than in non-expansion states.
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology.
There is an ongoing need for healthy volunteers in clinical research studies that can lead to healthcare breakthroughs that provide better drugs and treatments for patients.
TRIUMF, Canada’s particle accelerator centre, and Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson’s disease psychosis, researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system concluding that the new drug, pimavanserin (marketed as Nuplazid), did not pose a statistically significant greater risk of death.
.Johns Hopkins School of Nursing’s (JHSON) Cynda Rushton, PhD, RN, FAAN, has been chosen to serve on a newly formed National Academies of Science, Engineering, and Medicine committee to develop recommendations for systemic solutions to combating clinician burnout. Rushton was one of only two nurses selected for the committee.
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug—one with no known medical potential—to a schedule IV drug such as prescription sleep aids, but with tighter control.
CU Boulder researchers have identified a family of small molecules that turn off defense mechanisms inside bacteria that enable them to resist antibiotics. The compounds could ultimately be given alongside existing medications to rejuvenate them.
Restricting protein from a cancer patient’s diet may enhance the response to immunotherapy, according to an Indiana University cancer physician researcher.
A team of researchers including UCI project scientist Rachita Sumbria, PhD and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel tear.
Media can get a quick overview of what the CAP does, how it's expert member pathologists can add value to their stories.
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai. The study also demonstrated in mice that the drug, Metavert, may prevent patients from developing a resistance to currently used pancreatic cancer chemotherapies.
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide unprecedented response rates among stage 4 non-small cell lung cancer patients with genetic mutations that have previously defied treatment.
Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, according to a new study by a team including researchers from Johns Hopkins Bloomberg School of Public Health.
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers report.
Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more likely to become chronic opioid users than patients treated with minimally invasive surgery.
ISPOR, the professional society for health economics and outcomes research, announced plenary sessions and speakers for ISPOR Europe 2018, “New Perspectives for Improving 21st Century Health Systems." The conference is scheduled for 10-14 November in Barcelona, Spain.
Certified Registered Nurse Anesthetists (CRNAs) and other healthcare professionals will gather and discuss issues and solutions for enhanced recovery after surgery, access to quality anesthesia care, and technology’s role in healthcare, among other topics during the Nurse Anesthesia Annual Congress of the American Association of Nurse Anesthetists (AANA), Sept. 21-25, 2018, in Boston, Mass.
The inaugural lecture on diversity and inclusion is named after the American Association of Nurse Anesthetists’ 1973-1974 President, Goldie D. Brangman, MEd, MBA, CRNA. Brangman is the first and only African-American President of the AANA and will celebrate her 101st birthday in October.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
The University of Texas MD Anderson Cancer Center today joined with more than 450 communities and institutions across the country in hosting a Biden Cancer Community Summit, organized under the charge of the Biden Cancer Initiative. The Summit aims to encourage an ongoing dialogue about opportunities to make significant advances in cancer research, prevention, diagnosis and care.
A University of Arkansas at Little Rock spin-off company, NuShores Biosciences, LLC, has received a $1.7 million grant to study how NuShores’ bone regeneration technology can be applied in craniofacial tissues. The National Institute of Dental and Craniofacial Research, a component of the National Institutes of Health, has awarded the company a 2.
A small study shows that business managers and staff—such as those running coffee shops and fast-food restaurants—can be trained to reverse opioid overdoses, which are known to occur in public bathrooms.
Hurricane Florence made landfall in North and South Carolina days ago, but Penn Medicine Hospitals and other facilities nationwide have planned for weeks to adapt to expected drug shortages associated with its path of destruction.
Enthusiasm for an emerging digital health tool, the smart pill, is on the rise but researchers at the University of Illinois at Chicago have published a paper in the American Journal of Bioethics that cautions health care providers and policymakers to slow down when it comes to allowing this technology in patient care settings.
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this same historical growth trajectory for years to come.
Using a bioinformatics approach, University of California San Diego School of Medicine researchers found that CD4+ T cell’s binding partner, a molecule called MHC-II, may have even more influence on emerging tumors than MHC-I, the better known partner of CD8+ T cells. The finding, published September 20 in Cell, may help researchers improve cancer immunotherapies and predict which patients will respond best.
A new study published in the Journal of the American Heart Association shows disparities between the care given to black and white patients seeking treatment for a type of heart attack called NSTEMI (Non-ST-elevation myocardial infarction).
The medical community has long known that patients on long-term opioid therapy often have significantly more health care visits. But adhering to a standardized care process model for opioid prescriptions appears to reduce the overall number of health care visits for these patients while maintaining safety, shows new research published in Mayo Clinic Proceedings.
Under the three-year program, minority physicians will be recruited to conduct clinical trials—research studies that prospectively assign human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. The goal is to encourage more minority patients to participate in clinical trials by taking trials directly to minority patient populations.
Physician-scientists at The University of Kansas Cancer center are designing and initiating their own clinical trials.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right